FLUDEOXYGLUCOSE F 18


Synonyms	(18f)-fdg (18f)-fluorodeoxyglucose (18f)fdg (18f)fluoro-2-deoxyglucose (18f)fluorodeoxyglucose 18-FDG 18-f fdg 18FDG 18f 18f-fdg 18f-fluorodeoxyglucose 2-deoxy-2-(18f)fluoro-d-glucose 2-deoxy-2-fluoro-d-glucose, f-18 Fdg f-18 Fdg-pet Fludeoxyglucose ((sup 18)f) Fludeoxyglucose (18f) Fludeoxyglucose f 18 Fludeoxyglucose f(sup 18) Fludeoxyglucose f-18 Fludeoxyglucose f18 Fludeoxyglucose, f-18 Fluglucoscan Fluorine (18f) fludeoxyglucose Fluorine f 18 fluorodeoxyglucose Fluorodeoxyglucose f 18 Fluorodeoxyglucose f18 S8FDG
Status
Molecule Category	UNKNOWN
UNII	SBT3GBX27W
EPA CompTox	DTXSID50894178


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	ZCXUVYAZINUVJD-AHXZWLDOSA-N
Smiles	OC[C@H]1O[C@H](O)[C@H]([18F])[C@@H](O)[C@@H]1O
InChI	InChI=1S/C6H11FO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1H2/t2-,3-,4-,5-,6+/m1/s1/i7-1

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C6H11FO5
Molecular Weight	181.15
AlogP	-2.24
Hydrogen Bond Acceptor	5.0
Hydrogen Bond Donor	4.0
Number of Rotational Bond	1.0
Polar Surface Area	90.15
Molecular species	NEUTRAL
Aromatic Rings	0.0
Heavy Atoms	12.0

Bioactivity

Mechanism of Action	Action	Reference
Diagnostic agent	None	DailyMed

Related Entries

Cross References

Resources	Reference
ChEBI	31617
ChEMBL	CHEMBL1092067
DrugCentral	4455
FDA SRS	SBT3GBX27W
SureChEMBL	SCHEMBL135994
ZINC	ZINC000100073586

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).